Tag Archives: RENX

Best Value Stocks To Own For 2022

Dogecoin (CRYPTO: DOGE) traded 5.2% higher over 24 hours at  $0.256 in the early hours of Thursday.

What’s Moving? DOGE was down 15.28% over a seven-day trailing period. 

See Also: How To Buy Dogecoin (DOGE)

Against Bitcoin (CRYPTO: BTC), DOGE rose 2.35% while against Ethereum (CRYPTO: ETH) it fell 0.38% over 24 hours.

DOGE’s year-to-date gains stood at 4,399% at press time. The meme coin hit an all-time high of $0.74 in early May. 

What’s Moving? On Thursday, major cryptocurrencies traded in the green as the global cryptocurrency market cap rose 4.47% to $2.12 trillion. 

See Also: Has HEX Cryptocurrency Overtaken Cardano And Dogecoin In Market Capitalization?

DOGE did not attract high interest on Twitter at press time as it was mentioned 521 tweets. BTC, Solana (CRYPTO: SOL), and ETH topped the list of top 10 mentions on the social network, as per Cointrendz data. 

BTC, SOL and ETH were mentioned in 3,299, 1,555, and 1,306 tweets, respectively.

Major coins were seen recovering at press time. This follows $410 billion getting wiped off the crypto market value and $3 billion in long positions liquidated earlier in the week, as per GlobalBlock sales trader Alexandra Clark.

Best Value Stocks To Own For 2022: Wausau Paper Corp.(WPP)

WPP plc provides communications services worldwide. Its Advertising and Media Investment Management segment plans and creates marketing and branding campaigns; and designs and produces advertisements for television, cable, the Internet, and newspapers, as well as outdoor locations, such as billboards. This segment also engages in the media investment management operations in the areas of business science, consumer insight, communications and media planning implementation, interactions, content development, and sports and entertainment marketing. The companys Data Investment Management segment offers custom research services in various sectors, including strategic market studies; brand positioning; equity research; international research; advanced modeling; advertising research; pre-testing, tracking, and sales modeling; and trends and futures research and consultancy. Its Public Relations & Public Affairs segment advices its clients to communicate with consumers, governments, and the business and financial communities. This segments activities include corporate, financial, and marketing communications; crisis management; reputation management; public affairs; and government lobbying. The companys Branding & Identity, Healthcare, and Specialist Communications segment is involved in branding and identity; healthcare communications; and direct, digital, promotional, and relationship marketing activities. This segment also offers specialist communications services, such as custom media and multicultural marketing; event, sports, youth, and entertainment marketing; corporate and business-to-business; and media, technology, and production services, as well as provides digital and creating measurable interactive marketing, integrated digital marketing strategy, mobile solutions, and proprietary platforms services. WPP plc was formerly known as WPP 2012 plc. The company was founded in 1985 and is based in London, the United Kingdom.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Northern Trust Corp lifted its stake in Wpp Plc (NYSE:WPP) by 2.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,277,076 shares of the business services provider’s stock after purchasing an additional 27,084 shares during the quarter. Northern Trust Corp’s holdings in WPP were worth $100,352,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Shares of Wpp Plc (LON:WPP) have been assigned an average recommendation of “Hold” from the nineteen analysts that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is GBX 1,530.46 ($19.94).

  • [By Ethan Ryder]

    WPP (LON:WPP) had its price target lowered by Deutsche Bank AG from GBX 1,510 ($19.48) to GBX 1,430 ($18.45). The firm currently has a hold rating on the stock.

Best Value Stocks To Own For 2022: Brink's Company (BCO)

The Brink’s Company is a premier provider of secure logistics and security solutions including cash-in-transit, ATM replenishment and maintenance, international transportation of valuables, cash management and payment services. Our customers include financial institutions, retailers, government agencies (including central banks), mints, jewelers and other commercial operations around the world. Our global network serves customers in more than 100 countries. We have ownership interest in companies in 41 countries and agency relationships with companies in additional countries. We employ approximately 59,900 people and our operations include approximately 1,100 facilities and 12,000 vehicles.
Brink’s was founded in 1859 and The Brink’s Company was first incorporated in 1930 under the laws of the State of Delaware (at that time, the Company was named The Pittston Company).   Advisors’ Opinion:

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “Douglas A. Pertz Buys 5,000 Shares of Brink’s (BCO) Stock” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at www.tickerreport.com/banking-finance/4217246/douglas-a-pertz-buys-5000-shares-of-brinks-bco-stock.html.

  • [By Motley Fool Transcribing]

    Brink’s (NYSE:BCO) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Value Stocks To Own For 2022: ImmuCell Corporation(ICCC)

ImmuCell Corporation was founded in 1982 and completed an initial public offering of common stock in 1987. After achieving approval from the U.S. Department of Agriculture (USDA) to sell First Defense庐 in 1991, we focused most of our efforts during the 1990’s developing human product applications of the underlying milk protein purification technology. Beginning in 1999, we re-focused our business strategy on First Defense庐 and other products for the dairy and beef industries. During the first quarter of 2016, we sold 1.1 million shares of common stock in an underwritten public offering registered with the Securities and Exchange Commission (SEC), raising net proceeds of $5.3 million. Our purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries.   Advisors’ Opinion:

  • [By Max Byerly]

    ImmuCell Co. (NASDAQ:ICCC) Director David Scott Tomsche purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, August 16th. The stock was purchased at an average cost of $6.67 per share, with a total value of $20,010.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Best Value Stocks To Own For 2022: RELX N.V.(RENX)

RELX NV is a Netherlands-based company holding shares in RELX Group plc. RELX Group plc is a global provider of information and analytics for professional and business customers across industries. RELX Group plc serves customers in more than 180 countries. The Company operates in four market segments. Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity and improve outcomes. Risk & Business Analytics provides solutions and decision tools that combine public and industry-specific content with advanced technology and analytics. Legal is a provider of information and analytics to professionals in legal, corporate, government and non-profit organizations. Exhibitions organizes over 500 exhibitions a year, attracting more than seven million attendees. Shareholders in RELX NV own a 47.1% economic interest in RELX Group plc.

Scientific, Technical & Medical

The Company’s Scientific, Technical & Medical segment provides information and tools to help customers in scientific and healthcare outcomes. The Company is a provider of scientific, technical and medical information serving scientists, health professionals and students across the world. It is engaged in publishing primary research, reference and education content. It provides a range of database and workflow solutions. The Company caters to scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations and governments. It is engaged in the scientific, technical and medical reference market, providing authoritative and professional reference content. Its titles include various works, such as Gray’s Anatomy, Nelson’s Pediatrics and Netter’s Atlas of Human Anato! my. Its clinical reference platform, ClinicalKey, provides physicians with access to its third-party reference and evidence-based medical content in an integrated site. Its database and workflow products provide a range of tools and solutions for professionals in the science, technical, and medical fields, which caters to academic and corporate researchers, research administrators and healthcare professionals. For academic and corporate researchers, products include Scopus, Reaxys, and Knovel. It serves academic and government research administrators through its Elsevier Research Intelligence range of products. Its clinical solutions include ExitCare, which provides patient education and discharge information, and CPM Resource Center, which provides a data-driven framework to support nurses in undertaking procedures. Its journals include Cell and The Lancet families of titles. It operates in Amsterdam, Beijing, Boston, Chennai, Delhi, London, Madrid, Munich, New York, Oxford, Paris, Philadelphia, Rio de Janeiro, San Diego, Singapore and Tokyo.

Risk & Business Information

The Company’s Risk & Business Information segment provides data and analytics that enable customers to evaluate and manage risk. It develops market intelligence. It is organized around market-facing industry/sector groups, including insurance, business services, government, healthcare, data services, including banking, energy and chemicals, human resources and other brands. Insurance Solutions provides a combination of data and analytics to personal, commercial and life insurance carriers in the United States. Information solutions helps insurers assess risks and provide inputs to pricing and underwriting insurance policies. Its products include LexisNexis Data Prefill and LexisNexis Current Carrier. Its business services provides financial institutions with risk management, identity management, fraud detection, credit risk management and compliance solutions. These include Know Your Customer (KYC) and Anti-Mon! ey Launde! ring products. It also provides risk and identity management solutions for corporate customers in retail, telecommunications and utilities sectors. Government Solutions provides data and analytics to the United States federal, state and local law enforcement and government agencies to help solve criminal and intelligence cases and to identify fraud, waste and abuse in government programs. Health Care Solutions provides identity, fraud, and clinical analytics solutions across stages of the healthcare workflow to enable decision making for payers and providers. It also provides risk-related information to the legal industry through LexisNexis Legal & Professional. This segment provides information and online data services to business professionals across the world, with data services, information and tools, as well as producing conferences, Websites and business magazines. Its brands include Farmers Weekly, Boerderij, Fiscaal Totaal, Estates Gazette, Elsevier and New Scientist. It has operations in Georgia, Florida, Illinois and Ohio in the United States, as well as London, Amsterdam and Shanghai.

Legal

The Company’s Legal segment is a provider of legal, regulatory and news and business information, and analysis to law firm, corporate, government and academic customers. In North America, electronic information solutions and workflow tools from research solutions help legal and business professionals make decisions in the practice of law and in managing their businesses. Its products for legal research are Lexis.com and Lexis Advance. Research solutions also include news and business information, ranging from daily news to company filings, as well as public records information and analytics. LexisNexis also partners with law schools to provide services to students as part of their training. LexisNexis Business & Litigation Software Solutions serves as software arm for the Company. Its business of law software provides law firms with practice management solutions, including time an! d billing! systems, case management, cost recovery and document management services. Its litigation software provides lawyers with a range of tools covering case preparation to processing and review to trial preparation. In the markets outside the United States, LexisNexis serves legal, corporate, government, accounting and academic markets in Europe, Canada, Africa and Asia Pacific with local and international legal, regulatory and business information. In the United Kingdom, LexisNexis is a legal information provider. In France, LexisNexis is an online provider of information to lawyers, notaries and courts. Its brands include LexisNexis, Lexis, Matthew Bender, LexisLibrary, LexisPSL, Shepard’s Citations Service, Lexis Advance, Lexis Practice Advisor and Law360. It has operations in the New York area, Ohio and North Carolina in the United States, Toronto in Canada, London and Paris in Europe, and in Africa and Asia Pacific.

Exhibitions

The Company’s Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business, with approximately 500 events in over 30 countries. Reed Exhibitions’ portfolio of exhibitions and conferences serves over 40 industry sectors across the world. Its exhibitions and conferences encompass a range of sectors, which include construction, cosmetics, electronics, energy and alternative energy, engineering, entertainment, gifts and jewelry, healthcare, hospitality, interior design, logistics, manufacturing, pharmaceuticals, real estate, recreation, security and safety, transport and travel. Its brands include Mipim and World Travel Market.

The Company competes with Thomson Reuters, HIS, Wolters Kluwer, Platts, CCH (Wolters Kluwer), Bloomberg, Factiva (News Corporation), UBM, Informa IIR, Messe Frankfurt, Messe Dusseldorf and Messe Munich.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Relx (NYSE:RENX) was upgraded by research analysts at Barclays to a “buy” rating in a report released on Monday.

    RENX has been the subject of several other research reports. Zacks Investment Research raised shares of Relx from a “sell” rating to a “hold” rating in a report on Thursday, August 16th. UBS Group cut shares of Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $23.00.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Value Stocks To Own For 2022: S&P Smallcap 600(PH)

Parker Hannifin Corporation manufactures fluid power systems, electromechanical controls, and related components worldwide. Its Industrial segment offers pneumatic and electromechanical components, and systems; filters, systems, and instruments to monitor and remove contaminants from fuel, air, oil, water, and other liquids and gases; connectors that control, transmit, and contain fluid; hydraulic components and systems for builders and users of industrial and mobile machinery and equipment; critical flow components for process instrumentation, healthcare, and ultra-high-purity applications; and static and dynamic sealing devices. This segment sells its products to original equipment manufacturers (OEMs) and their replacement markets in the manufacturing, transportation, and processing industries. The company?s Aerospace segment provides flight control systems and components, including hydraulic, electrohydraulic, electric backup hydraulic, electrohydrostatic, and electro -mechanical components for precise control of aircraft rudders, elevators, ailerons, and other aerodynamic control surfaces. It also provides electronics thermal management heat rejection systems, and single-phase and two-phase heat collection systems for radar, ISAR, and power electronics. This segment markets its products primarily to OEMs in the commercial, military, and general aviation markets, as well as to end users. Its Climate and Industrial Controls segment offers systems and components primarily for use in the mobile and stationary refrigeration, and air conditioning industry; and in fluid control applications in various industries, such as processing, fuel dispensing, beverage dispensing, and mobile emissions. This segment serves OEMs and their replacement markets. Parker-Hannifin Corporation markets its products through direct-sales employees, independent distributors, wholesalers, and sales representatives. The company was founded in 1918 and is headquartered i n Cleveland, Ohio.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Commerzbank Aktiengesellschaft FI increased its holdings in shares of Parker-Hannifin Corp (NYSE:PH) by 9.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,709 shares of the industrial products company’s stock after acquiring an additional 3,348 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Parker-Hannifin were worth $5,624,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Parker-Hannifin (NYSE:PH) had its price target boosted by Wells Fargo & Co from $185.00 to $193.00 in a research note released on Thursday, The Fly reports. Wells Fargo & Co currently has a market perform rating on the industrial products company’s stock.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Parker-Hannifin (PH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Own Right Now

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-737546929&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/737546929/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

The Federal Reserve&a;rsquo;s increased aggression over the past couple of years has finally come home to roost. The yield on the 10-year Treasury recently rocketed above 2.8% &a;ndash; a four-year high &a;ndash; while the 30-year cleared the 3% mark.

That&a;rsquo;s bad news for investors in many traditional dividend-paying blue chips.

The 10-year T-note might as well have been a &a;ldquo;high-yield&a;rdquo; savings account the past few years, offering almost laughable income of less than 1.4% as recently as 2016. That kind of environment gives investors &a;ldquo;yield goggles,&a;rdquo; making even no-growth stocks look attractive as long as they&a;rsquo;re paying out near 3%.

Just look at the performance of the &l;b&g;Consumer Staples Select Sector SPDR &l;/b&g;&a;ndash; a collection of companies such as &l;b&g;Procter &a;amp; Gamble&l;/b&g; and &l;b&g;Coca-Cola&l;/b&g; &a;ndash; against the 10-year Treasury rate. While the XLP has broadly grown, it&a;rsquo;s strongest when the T-note&a;rsquo;s yield is in decline, and the fund typically stagnates or declines when the Treasury begins to deliver more income.

Top 10 Blue Chip Stocks To Own Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Relx (NYSE:RENX) was upgraded by research analysts at Barclays to a “buy” rating in a report released on Monday.

    RENX has been the subject of several other research reports. Zacks Investment Research raised shares of Relx from a “sell” rating to a “hold” rating in a report on Thursday, August 16th. UBS Group cut shares of Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $23.00.

Top 10 Blue Chip Stocks To Own Right Now: Voyager Therapeutics, Inc.(VYGR)

Advisors’ Opinion:

  • [By Chris Lange]

    For many drug developers, Parkinson’s disease is a tricky disease to treat. However, developing a treatment ultimately could yield a huge reward as there are currently no therapies that effectively slow or reverse the progression of this disease. And after Thursday’s announcement, Voyager Therapeutics Inc. (NASDAQ: VYGR) could be poised to reap this reward.

  • [By Max Byerly]

    Voyager Therapeutics (NASDAQ:VYGR) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

  • [By Trey Thoelcke]

    Voyager Therapeutics Inc. (NASDAQ: VYGR) also saw a director at the buy window last week. At an average of $18.31 apiece, the 3,000 shares reportedly acquired cost that director less than $55,000. Here too, a disappointing earnings report had shares down, offering an entry point. The stock was last seen up more than 12% from the purchase price, so seemingly a well-timed buy.

  • [By Max Byerly]

    Voyager Therapeutics (NASDAQ:VYGR)’s share price was down 3.3% during trading on Tuesday . The company traded as low as $20.45 and last traded at $21.04. Approximately 9,445 shares traded hands during trading, a decline of 98% from the average daily volume of 399,751 shares. The stock had previously closed at $20.37.

  • [By Keith Speights]

    Shares of Voyager Therapeutics (NASDAQ:VYGR) were skyrocketing 21.7% higher as of 11:22 a.m. EST on Friday. The small biotech announced a collaboration with AbbVie (NYSE:ABBV) to develop vectorized antibodies to treat Parkinson’s disease and other diseases characterized by the abnormal accumulation of misfolded alpha-synuclein protein.

Top 10 Blue Chip Stocks To Own Right Now: Carlisle Companies Incorporated(CSL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Carlisle Companies (CSL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
  • [By Shane Hupp]

    Press coverage about Carlisle Companies (NYSE:CSL) has trended somewhat positive on Saturday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Carlisle Companies earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave news coverage about the conglomerate an impact score of 45.7996936905604 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Carlisle Companies (CSL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Own Right Now: Dorman Products, Inc.(DORM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Dorman Products Inc. (NASDAQ:DORM) CEO Mathias J. Barton sold 18,986 shares of the company’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $81.34, for a total value of $1,544,321.24. Following the sale, the chief executive officer now owns 111,011 shares in the company, valued at approximately $9,029,634.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Dorman Products (DORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Shares of Dorman Products Inc. (NASDAQ:DORM) have received an average rating of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $68.33.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Dorman Products (DORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Honeywell (NYSE: HON) and Dorman Products (NASDAQ:DORM) are both multi-sector conglomerates companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Top 10 Blue Chip Stocks To Own Right Now: Information Services Group Inc.(III)

Advisors’ Opinion:

  • [By Joseph Griffin]

    3i Group (LON:III) had its price target upped by Societe Generale from GBX 1,020 ($13.58) to GBX 1,130 ($15.04) in a research note released on Thursday. The brokerage currently has a buy rating on the stock.

  • [By Joseph Griffin]

    RMR Group (NASDAQ: RMR) and Information Services Group (NASDAQ:III) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Martingale Asset Management L P bought a new position in Information Services Group, Inc. Common Stock (NASDAQ:III) during the second quarter, Holdings Channel reports. The fund bought 110,416 shares of the business services provider’s stock, valued at approximately $453,000.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Own Right Now: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By Lee Samaha]

    As you can see in the table above, Resource Industries is currently the smallest segment, but its cyclical recovery is crucial to Caterpillar meeting its guidance. The problem here is that metals and minerals prices have been declining in the last six months, and this calls into question the idea that miners are in the early innings of a long cycle of investment. Throw in talk of near-term weakness from companies like Cummins (NYSE:CMI) — and Caterpillar for that matter — and the outlook is uncertain.

  • [By Ethan Ryder]

    Mission Wealth Management LP lessened its holdings in shares of Cummins Inc. (NYSE:CMI) by 12.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,604 shares of the company’s stock after selling 786 shares during the period. Mission Wealth Management LP’s holdings in Cummins were worth $749,000 at the end of the most recent reporting period.

  • [By Neha Chamaria, Jason Hall, and Dan Caplinger]

    So we asked three Motley Fool contributors to pick a stock famed investors are currently buying. Here’s why Cummins (NYSE:CMI), CenturyLink (NYSE:CTL), and Southwest Airlines (NYSE:LUV) caught their attention.

  • [By Rich Smith]

    Over the last 12 months, shares of PACCAR (NASDAQ:PCAR) are down 5%, Cummins (NYSE:CMI) stock is off by 14%, and WABCO (NYSE:WBC) is down more than 18%. Yesterday, the news promised to get worse before it gets better — January orders for Class 8 trucks declined 68% year over year, and orders for smaller Class 5-7 trucks were down 24%, according to TheFly.com (citing a JPMorgan report).

Top 10 Blue Chip Stocks To Own Right Now: Summer Infant Inc.(SUMR)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Summer Infant alerts:

    How Financially Strong Is Summer Infant Inc (NASDAQ:SUMR)? (finance.yahoo.com) Summer Infant, Inc. (SUMR) Director Buys $10,800.00 in Stock (americanbankingnews.com) Head-To-Head Survey: Summer Infant (SUMR) vs. Smiths Group (SMGZY) (americanbankingnews.com) Summer Infant Announces Upcoming Investor Events (finance.yahoo.com) Summer Infant, Inc. (SUMR) Receives Average Rating of “Strong Buy” from Analysts (americanbankingnews.com)

    SUMR has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of Summer Infant from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 25th. ValuEngine cut shares of Summer Infant from a “buy” rating to a “hold” rating in a research note on Tuesday, February 27th. Finally, Roth Capital reiterated a “buy” rating on shares of Summer Infant in a research note on Thursday, February 22nd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Summer Infant presently has an average rating of “Buy” and a consensus price target of $2.50.

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summer Infant (SUMR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summer Infant (SUMR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Own Right Now: Village Super Market Inc.(VLGEA)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub upgraded shares of Village Super Market (NASDAQ:VLGEA) from a sell rating to a hold rating in a research report report published on Tuesday.

  • [By Logan Wallace]

    Village Super Market, Inc. Class A (NASDAQ: VLGEA) and Koninklijke Ahold (OTCMKTS:ADRNY) are both retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

  • [By Ethan Ryder]

    BidaskClub lowered shares of Village Super Market (NASDAQ:VLGEA) from a hold rating to a sell rating in a report published on Tuesday.

    Shares of VLGEA stock opened at $27.20 on Tuesday. Village Super Market has a 52-week low of $21.95 and a 52-week high of $31.49. The company has a quick ratio of 1.38, a current ratio of 1.81 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $392.70 million, a price-to-earnings ratio of 13.80 and a beta of 0.04.

  • [By Joseph Griffin]

    Media stories about Village Super Market, Inc. Class A (NASDAQ:VLGEA) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Village Super Market, Inc. Class A earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 43.9608995956738 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Blue Chip Stocks To Own Right Now: Evans Bancorp, Inc.(EVBN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Evans Bancorp (NYSEAMERICAN:EVBN) was downgraded by investment analysts at Hovde Group from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Monday. They presently have a $50.00 price objective on the bank’s stock. Hovde Group’s price target would suggest a potential upside of 6.16% from the stock’s previous close.

  • [By Max Byerly]

    LSV Asset Management boosted its stake in shares of Evans Bancorp Inc. (NYSEAMERICAN:EVBN) by 93.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,200 shares of the bank’s stock after purchasing an additional 2,513 shares during the period. LSV Asset Management’s holdings in Evans Bancorp were worth $239,000 at the end of the most recent reporting period.

Top 10 Blue Chip Stocks To Own Right Now: CPI Aerostructures, Inc.(CVU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Penn Capital Management Co. Inc. lessened its holdings in shares of CPI Aero (NYSEAMERICAN:CVU) by 22.5% in the 1st quarter, Holdings Channel reports. The firm owned 253,588 shares of the aerospace company’s stock after selling 73,720 shares during the quarter. Penn Capital Management Co. Inc.’s holdings in CPI Aero were worth $2,472,000 as of its most recent filing with the SEC.

  • [By Lisa Levin]

    CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

    SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.

Top 5 Clean Energy Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-951753282&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/951753282/960×0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; A worker installs solar panels atop a house in the Netherlands. (Photo by Yuriko Nakao/Getty Images)

&l;p class=&q;tweet_line&q;&g;More than half a million jobs around the world were created in the renewable energy sector in 2017 , bringing the total number of people employed in the sector to more than 10 million for the first time.

Figures from the International Renewable Energy Agency (IRENA) show that more than 70% of clean energy jobs are in just six countries &a;ndash; China, Brazil, the US, India, Germany and Japan &a;ndash; suggesting the sector has significant scope to continue growing in years to come.

IRENA&a;rsquo;s fifth &l;em&g;Renewable Energy and Jobs &a;ndash; Annual Review&l;/em&g; showed that the sector employs 10.3 million workers, with 60% of jobs in Asia. &a;ldquo;Although growing numbers of countries are reaping the socio-economic benefits of renewables, the bulk of manufacturing takes place in relatively few countries and domestic markets vary enormously in size,&a;rdquo; IRENA said.

Top 5 Clean Energy Stocks To Invest In Right Now: Wynn Resorts, Limited(WYNN)

Advisors’ Opinion:

  • [By Lee Jackson]

    This top company saw the departure of its namesake founder earlier this year. Wynn Resorts Ltd. (NASDAQ: WYNN) operates Wynn Macau and Encore at Wynn Macau resort located in the People’s Republic of China.

  • [By Rich Duprey]

    Yet not all casinos will benefit equally. Las Vegas Sands (NYSE:LVS) and Wynn Resorts (NASDAQ:WYNN), for example, derive most of their revenues from operations in Macau. Sands earns 60% there; Wynn, 73%. They could certainly expand their sports books beyond their Vegas operations, but they have so few casinos elsewhere (and Wynn’s Boston Harbor isn’t even completed), it’s only going to be a tiny portion of their overall revenues.

  • [By Travis Hoium]

    Encore Boston Harbor, Wynn Resorts, Limited’s (NASDAQ:WYNN) $2.5 billion resort under construction near downtown Boston, may be up for sale — again — as gaming regulators mull whether the company will keep its gaming license in the state. Regulators have been concerned about Wynn’s corporate governance since allegations of sexual misconduct against founder Steve Wynn came to light earlier this year.

  • [By Travis Hoium]

    Wynn Resorts (NASDAQ:WYNN) has been on a growth tear since opening Wynn Palace in Macau two years ago, but that’s not the end of the company’s ambitions. There’s room to expand in existing markets like Las Vegas and Macau, and new markets to conquer like Boston and Japan. 

  • [By Rich Duprey]

    The future of Wynn Resorts (NASDAQ:WYNN) could be in doubt as The New York Post reported MGM Resorts (NYSE:MGM) may be interested in buying its rival. Although MGM CEO Jim Murren previously said his resort was unlikely to make a play, the resignation of founder Steve Wynn and the sale of all of his stock in the casino giant now makes a takeover bid more palatable.

  • [By Jeremy Bowman, George Budwell, and Travis Hoium]

    By now, most investors are familiar with the FAANG group of tech stocks that have driven much of the market’s growth in recent years. The success of stocks like Facebook and Amazon show that investing can be as easy as buying shares in companies whose products you use everyday, but there are also stocks that are flying under the radar that you should get to know. These offer investors the opportunity for even bigger returns since smaller-cap stocks have a greater potential for growth. In-the-know investors are catching on to some of these names. Keep reading to learn more about Baozun (NASDAQ:BZUN), Wynn Resorts (NASDAQ:WYNN), and Viking Therapeutics (NASDAQ:VKTX).

Top 5 Clean Energy Stocks To Invest In Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Relx (NYSE:RENX) was upgraded by research analysts at Barclays to a “buy” rating in a report released on Monday.

    RENX has been the subject of several other research reports. Zacks Investment Research raised shares of Relx from a “sell” rating to a “hold” rating in a report on Thursday, August 16th. UBS Group cut shares of Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $23.00.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Clean Energy Stocks To Invest In Right Now: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Starbucks Corp. (NASDAQ: SBUX) needs to be restructured, refined and refocused. The management decision to reorganize the coffee company will come with large layoffs. Company CEO and president, Kevin Johnson, will not be among those who will depart. However, many Starbucks problems have occurred over the course of his tenure, and last year he was paid $11.5 million for his leadership.

  • [By Motley Fool Staff]

    Barker: Yeah, it’s a little jarring, “McDonald’s restaurants,” because I guess the image I have, in my head at least, of a restaurant is a little bit more of a sit-down experience than the counter experience. This is not a shot at McDonald’s, although we could go in that direction if you have a good line or something, but I feel the same way about Starbucks (NASDAQ:SBUX) also included in the restaurant category.

  • [By Jon C. Ogg]

    Starbucks Corp. (NASDAQ: SBUX) continues to face headwinds as investors and consumers see a maturing brand that is finding limited options for organic growth. After the close on Tuesday, Starbucks announced that the company was raising its target for cash returned to shareholders to $25 billion through fiscal year 2020, and that includes a 20% increase in the company’s common stock dividend. Unfortunately, Starbucks also lowered its internal growth metrics and its shares were lower as a result.

  • [By Chris Lange]

    Starbucks Corp. (NASDAQ: SBUX) was started as Neutral at Wedbush and assigned a $58 price target (versus a $57.68 close). The firm no longer sees risks to fiscal 2019 expectations and long-term management targets. The firm also does not expect near-term drivers of positive revisions to materialize.

  • [By Douglas A. McIntyre]

    Nestle will pay Starbucks Corp. (NASDAQ: SBUX) over $7 billion to help the distribution of coffee worldwide by both companies. According to Reuters:

Top 5 Clean Energy Stocks To Invest In Right Now: Diana Containerships Inc.(DCIX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Diana Containerships Inc (NASDAQ:DCIX) saw strong trading volume on Wednesday . 738,970 shares were traded during mid-day trading, a decline of 4% from the previous session’s volume of 766,564 shares.The stock last traded at $1.24 and had previously closed at $1.12.

  • [By Lisa Levin] Gainers
    Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01.
    iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73.
    Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009.
    Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.
    Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
    Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
    Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday.
    OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15.
    Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74.
    Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday.
    Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
    Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40
  • [By Stephan Byrd]

    Diana Containerships Inc (NASDAQ:DCIX)’s share price traded up 0.8% during mid-day trading on Wednesday . The stock traded as high as $1.41 and last traded at $1.27. 9,477 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 293,509 shares. The stock had previously closed at $1.28.

Top 5 Clean Energy Stocks To Invest In Right Now: Garrison Capital Inc.(GARS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Garrison Capital (NASDAQ:GARS) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

  • [By Joseph Griffin]

    Garrison Capital (NASDAQ: GARS) and Amern Cap Sr Fl/COM (NASDAQ:ACSF) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

  • [By Ethan Ryder]

    Garrison Capital (NASDAQ:GARS)‘s stock had its “buy” rating restated by stock analysts at National Securities in a research report issued on Monday. They currently have a $10.00 target price on the investment management company’s stock. National Securities’ price objective would indicate a potential upside of 18.91% from the stock’s current price.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Garrison Capital (GARS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Garrison Capital (GARS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Garrison Capital (NASDAQ: GARS) and PennantPark Investment (NASDAQ:PNNT) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Top 10 Medical Stocks To Invest In Right Now

Meet the Annuity Trust on Bernie Sanders Hit List

How to Get Medicaid for Nursing Home Care Without Going Broke

10 States Where the Millennials Are More Obese Than the Seniors

The $475,000 price tag on Novartis AG’s latest breakthrough cancer therapy came under fire from one of the biggest managers of drug costs in the United States, underscoring the challenges the Swiss drugmaker will face in promoting the potential blockbuster.

The cost of the leukemia treatment, called Kymriah, is “dramatically higher” than other such complex treatments, and the health care system isn’t ready to pay for it, Steve Miller, chief medical officer at Express Scripts Holding Co., said Thursday in a blog post on his company’s website. Gene therapies like Novartis’s are targeted at a small number of patients and typically used just once, meaning that drug companies have limited chances to recoup their investment.

“Therein lies the challenge,” Miller wrote. “We need a new payment model.”

Top 10 Medical Stocks To Invest In Right Now: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Connecticut Water Service (NASDAQ: CTWS) and Aqua America (NYSE:WTR) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

Top 10 Medical Stocks To Invest In Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    For example, I used finvizin the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Max Byerly]

    Swiss National Bank grew its holdings in HealthEquity (NASDAQ:HQY) by 3.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,800 shares of the company’s stock after purchasing an additional 2,900 shares during the quarter. Swiss National Bank owned approximately 0.15% of HealthEquity worth $5,376,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider ofTaser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-ledpayroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE)– The company’s push to the cloud is drivingdouble-digitgains in revenue and profits. AppFolio (NASDAQ: APPF) — Asoftware-as-a-service provider focused on servicing business owners in severalniche markets. BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century.

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here.

  • [By Max Byerly]

    ValuEngine upgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research report report published on Tuesday morning.

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

Top 10 Medical Stocks To Invest In Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Stifel Financial Corp cut its stake in shares of Genesis Energy, L.P. common stock (NYSE:GEL) by 1.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 450,749 shares of the pipeline company’s stock after selling 7,788 shares during the quarter. Stifel Financial Corp owned about 0.37% of Genesis Energy, L.P. common stock worth $8,884,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Genesis Energy, L.P. common stock (GEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Blair William & Co. IL cut its stake in Genesis Energy, L.P. common stock (NYSE:GEL) by 21.6% in the first quarter, HoldingsChannel.com reports. The fund owned 55,817 shares of the pipeline company’s stock after selling 15,409 shares during the period. Blair William & Co. IL’s holdings in Genesis Energy, L.P. common stock were worth $1,100,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Medical Stocks To Invest In Right Now: Compass Diversified Holdings(CODI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Schroder Investment Management Group grew its stake in Compass Diversified Holdings (NYSE:CODI) by 3.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,097,576 shares of the financial services provider’s stock after purchasing an additional 33,776 shares during the period. Schroder Investment Management Group owned approximately 1.83% of Compass Diversified worth $18,000,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Ray Benjamin M. Anderson sold 1,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $184.88, for a total value of $184,880.00. Following the completion of the transaction, the director now owns 1,989 shares in the company, valued at $367,726.32. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

  • [By Logan Wallace]

    Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top 10 Medical Stocks To Invest In Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about American Financial Group (NYSE:AFG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. American Financial Group earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.840441381164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Westpac Banking Corp increased its stake in shares of American Financial Group (NYSE:AFG) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,403 shares of the insurance provider’s stock after purchasing an additional 709 shares during the quarter. Westpac Banking Corp’s holdings in American Financial Group were worth $831,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on American Financial Group (AFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: OneMain Holdings, Inc.(OMF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OneMain (OMF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    In a sea of red, small-cap biotech stocks stood strong during Wednesdays trading session. The SPDR S&P Biotech ETF (NYSE:XBI) finished the day higher by more than 1.25% while the Nasdaq Composite was stuck in the red. XBIs comeback rally that began to materialize just before Christmas is now threatening to break out to new highs.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. TheSPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell

Top 10 Medical Stocks To Invest In Right Now: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.